• Home
  • About Us
    • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Management Team
    • Careers
  • For Researchers
    • Paxalisib
    • EVT801
    • Collaborating with Kazia
    • Publications and Presentations
  • For Partners
    • Our Current Partners
    • What We Are Looking For
  • For Patients
    • Accessing Kazia Drug Candidates in Clinical Trials
    • Accessing Kazia Drug Candidates for Compassionate Use
    • Resources for Patients
  • For Investors
    • Press Releases
    • ASX Announcements
    • Delisting from ASX
      • How to convert unlisted shares to ADSs
    • SEC Filings
    • Corporate Presentations
    • Annual Reports
    • Financial Reports
    • AGM
    • Corporate Governance
    • Shareholder Services
  • Media Centre
    • Overview
    • Video
    • Coverage
  • Contact
    • Contact Us
    • Subscribe to email alerts
Kazia Therapeutics Limited
Heading &
Sub-heading can be edited through HQI
Home > For Researchers > Publications and Presentations
  • Paxalisib
  • EVT801
  • Collaborating with Kazia
  • Publications and Presentations

Publications and Presentations

21-Sep-2024
EVT801 Presentation at the 15th Biennial Ovarian Cancer Research Symposium
11-Apr-2024
EVT801 Phase 1 clinical trial poster presentation at AACR 2024
11-Apr-2024
EVT801 Phase 1 biomarker analysis poster presentation at AACR 2024
24-Oct-2023
EVT801 Phase 1 clinical trial poster presentation from ESMO 2023
25-May-2023
EVT801 Phase I Clinical Trial poster presented at AACR23
17-May-2023
Cancer Research publishes pre-clinical findings on DIPG/DMG trial
25-Oct-2022
Poster at Int. Congress of the Society for Melanoma Research
3-Jun-2022
Paxalisib phase II study poster presented as ASCO 2022
4-Jun-2021
Kazia Therapeutics to present at LD Micro Invitational XI
21-Nov-2020
Paxalisib poster presented at SNO (virtual meeting)
22-Jun-2020
Paxalisib poster presented at AACR (virtual meeting)
1-Jun-2020
Paxalisib poster presented at ASCO (virtual meeting)
Click here for archives
 

Quick Links

Contact Us

Kazia Therapeutics Limited
Three International Towers
Level 24, 300 Barangaroo Avenue
Sydney NSW 2000, Australia

info@kaziatherapeutics.com
https://www.kaziatherapeutics.com

Subscribe to Email Alerts

Which of the following group do you best fit?

 

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Kazia Therapeutics Limited
Site Map Privacy Search
Design byspatialdesign Site by